ERBB2 and cancer: In conclusion, in this proof‐of‐principle experiments, we assessed that ONCE‐derived cfDNA and EV represent an informative source for investigating cancer biomarkers, such as HER2, in the circulation, as genomic and molecular features are representative of matched tissue‐based investigations.